OBJECTIVES: (2-succinyl)cysteine (2SC) is formed by a Michael addition reaction of the Krebs cycle intermediate, fumarate, with cysteine residues in protein. We investigated the role of fumarate in chemical modification and inhibition of the sulfhydryl enzyme, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), in vitro and in tissues of diabetic rats. RESEARCH DESIGN AND METHODS: GAPDH was incubated with fumarate in PBS to assess effects of fumarate on enzyme activity in vitro. Sites of 2SC formation were determined by analysis of tryptic peptides by high-performance liquid chromatography-quadrupole/time-of-flight mass spectrometry. 2SC and fumarate in gastrocnemius muscle of control and streptozotocin-induced diabetic rats were measured by liquid chromatography/tandem mass spectrometry and by gas chromatography/mass spectrometry, respectively. GAPDH was isolated from muscle by immunoprecipitation, and sites of modification of GAPDH were determined by mass spectrometry analysis. RESULTS: 2SC was found, both in vitro and in vivo, about equally at active-site Cys-149 and nucleophilic Cys-244. Inactivation of GAPDH by fumarate in vitro correlated with formation of 2SC. In diabetic compared with control rats, fumarate and 2SC concentration increased approximately fivefold, accompanied by an approximately 25% decrease in GAPDH specific activity. The fractional modification of GAPDH by 2SC was significantly increased in diabetic versus control animals, consistent with the decreased specific activity of GAPDH in muscle of diabetic animals. CONCLUSIONS: Fumarate contributes to inactivation of GAPDH in diabetes. 2SC may be a useful biomarker of mitochondrial stress in diabetes. Modification of GAPDH and other enzymes and proteins by fumarate may contribute to the metabolic changes underlying the development of diabetes complications.
OBJECTIVES:(2-succinyl)cysteine (2SC) is formed by a Michael addition reaction of the Krebs cycle intermediate, fumarate, with cysteine residues in protein. We investigated the role of fumarate in chemical modification and inhibition of the sulfhydryl enzyme, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), in vitro and in tissues of diabeticrats. RESEARCH DESIGN AND METHODS: GAPDH was incubated with fumarate in PBS to assess effects of fumarate on enzyme activity in vitro. Sites of 2SC formation were determined by analysis of tryptic peptides by high-performance liquid chromatography-quadrupole/time-of-flight mass spectrometry. 2SC and fumarate in gastrocnemius muscle of control and streptozotocin-induced diabeticrats were measured by liquid chromatography/tandem mass spectrometry and by gas chromatography/mass spectrometry, respectively. GAPDH was isolated from muscle by immunoprecipitation, and sites of modification of GAPDH were determined by mass spectrometry analysis. RESULTS:2SC was found, both in vitro and in vivo, about equally at active-site Cys-149 and nucleophilic Cys-244. Inactivation of GAPDH by fumarate in vitro correlated with formation of 2SC. In diabetic compared with control rats, fumarate and 2SC concentration increased approximately fivefold, accompanied by an approximately 25% decrease in GAPDH specific activity. The fractional modification of GAPDH by 2SC was significantly increased in diabetic versus control animals, consistent with the decreased specific activity of GAPDH in muscle of diabetic animals. CONCLUSIONS:Fumarate contributes to inactivation of GAPDH in diabetes. 2SC may be a useful biomarker of mitochondrial stress in diabetes. Modification of GAPDH and other enzymes and proteins by fumarate may contribute to the metabolic changes underlying the development of diabetes complications.
Authors: T Nishikawa; D Edelstein; X L Du; S Yamagishi; T Matsumura; Y Kaneda; M A Yorek; D Beebe; P J Oates; H P Hammes; I Giardino; M Brownlee Journal: Nature Date: 2000-04-13 Impact factor: 49.962
Authors: Frederico G S Toledo; Elizabeta V Menshikova; Vladimir B Ritov; Koichiro Azuma; Zofia Radikova; James DeLany; David E Kelley Journal: Diabetes Date: 2007-05-29 Impact factor: 9.461
Authors: Thomas D Niehaus; Jacob Folz; Donald R McCarty; Arthur J L Cooper; David Moraga Amador; Oliver Fiehn; Andrew D Hanson Journal: J Biol Chem Date: 2018-04-06 Impact factor: 5.157
Authors: Vladislav A Petyuk; Wei-Jun Qian; Charlotte Hinault; Marina A Gritsenko; Mudita Singhal; Matthew E Monroe; David G Camp; Rohit N Kulkarni; Richard D Smith Journal: J Proteome Res Date: 2008-06-21 Impact factor: 4.466
Authors: Eric D Merkley; Thomas O Metz; Richard D Smith; John W Baynes; Norma Frizzell Journal: Mass Spectrom Rev Date: 2013-09-30 Impact factor: 10.946
Authors: Gerardo G Piroli; Allison M Manuel; Michael D Walla; Matthew J Jepson; Jonathan W C Brock; Mathur P Rajesh; Ross M Tanis; William E Cotham; Norma Frizzell Journal: Biochem J Date: 2014-09-01 Impact factor: 3.857
Authors: Michael D Kornberg; Pavan Bhargava; Paul M Kim; Vasanta Putluri; Adele M Snowman; Nagireddy Putluri; Peter A Calabresi; Solomon H Snyder Journal: Science Date: 2018-03-29 Impact factor: 47.728